Literature DB >> 7943248

Protein kinase A mediates activation of ATP-sensitive K+ currents by CGRP in gallbladder smooth muscle.

L Zhang1, A D Bonev, G M Mawe, M T Nelson.   

Abstract

The signal transduction mechanisms underlying the activation of ATP-sensitive potassium (KATP) current by calcitonin gene-related peptide (CGRP) in gallbladder smooth muscle were examined with intracellular microelectrode recording and whole cell patch-clamp techniques. In the intact gallbladder preparation, the adenylyl cyclase activator forskolin hyperpolarized the membrane potential and abolished spontaneous action potentials. This response was inhibited by the KATP channel blocker glibenclamide. CGRP (10 nM), forskolin (10 microM), the membrane-permeable adenosine 3',5'-cyclic monophosphate (cAMP) analogue adenosine 3',5'-cyclic monophosphothioate (Sp-cAMP[S]; 500 microM), and the catalytic subunit of protein kinase A (100 U/ml) activated glibenclamide-sensitive currents in enzymatically dissociated gallbladder smooth muscle cells. CGRP activation of potassium currents was prevented by dialysis of the cell cytoplasm with guanosine 5'-O-(2-thiodiphosphate) (5 mM) or a specific peptide inhibitor of protein kinase A (2.3 microM). Okadaic acid (5 microM), a phosphatase inhibitor, slowed the deactivation of the KATP current, following removal of CGRP. The results of this study indicate that CGRP hyperpolarizes gallbladder smooth muscle by elevation of cAMP and subsequent stimulation of protein kinase A.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7943248     DOI: 10.1152/ajpgi.1994.267.3.G494

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  20 in total

Review 1.  Postjunctional electrical mechanisms of enteric neurotransmission.

Authors:  K M Sanders
Journal:  Gut       Date:  2000-12       Impact factor: 23.059

Review 2.  A little humour relaxes the gallbladder.

Authors:  Simon J Gibbons
Journal:  J Physiol       Date:  2010-09-01       Impact factor: 5.182

Review 3.  Muscle KATP channels: recent insights to energy sensing and myoprotection.

Authors:  Thomas P Flagg; Decha Enkvetchakul; Joseph C Koster; Colin G Nichols
Journal:  Physiol Rev       Date:  2010-07       Impact factor: 37.312

4.  Hydrophobic bile salts inhibit gallbladder smooth muscle function via stimulation of GPBAR1 receptors and activation of KATP channels.

Authors:  Brigitte Lavoie; Onesmo B Balemba; Cody Godfrey; Conall A Watson; Galya Vassileva; Carlos U Corvera; Mark T Nelson; Gary M Mawe
Journal:  J Physiol       Date:  2010-07-12       Impact factor: 5.182

5.  Inhibitory effect of caffeine on pacemaker activity in the oviduct is mediated by cAMP-regulated conductances.

Authors:  Re Dixon; Sj Hwang; Fc Britton; Km Sanders; Sm Ward
Journal:  Br J Pharmacol       Date:  2011-06       Impact factor: 8.739

6.  Prostatic relaxation induced by loperamide is mediated through activation of opioid μ-2 receptors in vitro.

Authors:  Chih-Cheng Lu; Hsien-Hui Chung; Juei-Tang Cheng
Journal:  Exp Ther Med       Date:  2011-01-20       Impact factor: 2.447

Review 7.  Role of CGRP-receptor component protein (RCP) in CLR/RAMP function.

Authors:  Ian M Dickerson
Journal:  Curr Protein Pept Sci       Date:  2013-08       Impact factor: 3.272

8.  Distinct effects of CGRP on typical and atypical smooth muscle cells involved in generating spontaneous contractions in the mouse renal pelvis.

Authors:  Hikaru Hashitani; Richard J Lang; Retsu Mitsui; Yoshio Mabuchi; Hikaru Suzuki
Journal:  Br J Pharmacol       Date:  2009-12       Impact factor: 8.739

9.  The sulphonylurea receptor SUR1 regulates ATP-sensitive mouse Kir6.2 K+ channels linked to the green fluorescent protein in human embryonic kidney cells (HEK 293).

Authors:  S A John; J R Monck; J N Weiss; B Ribalet
Journal:  J Physiol       Date:  1998-07-15       Impact factor: 5.182

10.  Role of intracellular Ca2+ in the K channel opener action of CGRP in the guinea-pig ureter.

Authors:  C A Maggi; S Giuliani; P Santicioli; A F Brading
Journal:  Br J Pharmacol       Date:  1996-07       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.